E
Ellipsis Health
AI-powered vocal biomarker technology for scalable identification and management of depression and anxiety
About Ellipsis Health
Ellipsis Health is a healthcare technology company that has developed a system to screen for and monitor behavioral health conditions like depression and anxiety using a person's voice. The company's technology is based on artificial intelligence and machine learning algorithms that analyze speech patterns to identify vocal biomarkers associated with mental health conditions. This allows for a non-invasive and scalable way to assess mental well-being.
The company primarily serves healthcare providers and organizations, offering them a tool to integrate into their existing workflows. This enables clinicians to get a more objective measure of a patient's mental health status, which can aid in early detection and more effective treatment planning. The business model is likely a B2B approach, where healthcare partners pay to use the technology, possibly through a subscription or a fee-per-use model.
By providing a tool for early and continuous monitoring, Ellipsis Health aims to improve patient outcomes and reduce the costs associated with untreated or poorly managed mental health conditions. The technology is designed to be used remotely, making it accessible to a wide range of patients, including those in underserved areas.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- San Francisco, United States
- Employees
- 84
- Open positions
- 16
- Dealroom signal
- 92.5/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Remote Monitoring, Mental Health, Core AI, Hard Tech, AI Applications, remote health monitoring, DT and LS, science-based
- Technology
- Artificial Intelligence, Deep Tech, Machine Learning
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Jun 2025 | $45M | $180M | Mitsui Global Investment · AME Cloud Ventures · E12 Ventures · Salesforce | ↗ |
| EARLY VCOther financing | Mar 2024 | $100K | $400K | One Mind | ↗ |
Growth signals
Latest recorded traffic for Ellipsis Health is 9.7K monthly website visits, up 7.8% over the last three months. Ellipsis Health's team grew 29.2% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Khosla Ventures
City Light Capital- APAkhil Paul
Richard Socher
Series A14 investors entered at this stage
SJF Ventures
Marc Benioff
Alumni Ventures
What If Ventures
Greycroft Partners
Generator Ventures
Luminous Ventures- APAble Partners
One Mind
Salesforce
CVS Health Ventures
Mitsui Global Investment
AME Cloud Ventures
E12 Ventures
Other known investors1 additional known investor
One Mind Accelerator
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ellipsis Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ellipsis Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.